EXPANDING RT-PCR based testing to diseases other than Covid-19, vaccine formats that obviate the need for cold chains, portable and cutting-edge wearables, and AI-based diagnostic solutions that can be activated on a cellphone. Rewiring and tweaking existing medical technologies and diagnostic methods — primarily in the wake of the Covid-19 pandemic — was the overarching theme at the two-day Biotech Startup Expo 2022 in the capital which ended on Friday.
There were over 300 stalls spanning the biotech spectrum — medical technology, agricultural tech, diagnostics, vaccine technology, biotech incubators etc.
Tucked in a corner of the Expo hall at the newly-built Pragati Maidan complex in New Delhi was a stall of Graphic Era Deemed University, Dehradun, where three senior professors from the biotechnology department stood in front of a marquee that read “RT-PCR based testing for typhoid”.
“The current method for detecting salmonella typhi (for typhoid) is an elaborate one, but is still quite inaccurate. Our research department has developed and patented an RT-PCR based testing kit to detect the disease,” Navin Kumar, Professor and Head of Biotechnology at Graphic Era, said.
Source: kfindtech.com
